Showing results (511-520 of 3,353) with videos related to
Sort By:
Pageof 336
The Lancet. Oncology|February 26, 2013
New policies to address the global burden of childhood cancersRichard Sullivan, Jerzy R Kowalczyk, Bharat Agarwal, et al.The Lancet. Oncology|February 26, 2013
Paediatric cancer in low-income and middle-income countriesIan Magrath, Eva Steliarova-Foucher, Sidnei Epelman, et al.The Lancet. Oncology|November 28, 2012
Cancer and men who have sex with men: a systematic reviewUlrike Boehmer, Timothy P Cooley, Melissa A ClarkThe Lancet. Oncology|November 28, 2012
Novel diagnostic modalities for assessment of the clinically node-negative neck in oral squamous-cell carcinomaFrank K J Leusink, Robert J J van Es, Remco de Bree, et al.The Lancet. Oncology|December 14, 2012
Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trialPaul E Goss, Ian E Smith, Joyce O'Shaughnessy, et al.The Lancet. Oncology|December 4, 2012
Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 studyPasi A Jänne, Alice T Shaw, José Rodrigues Pereira, et al.The Lancet. Oncology|December 11, 2012
Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort studyFabio A B Schutz, Mark M Pomerantz, Kathryn P Gray, et al.The Lancet. Oncology|January 2, 2013
Molecular diagnostics in paediatric glial tumoursJoon-Hyung Kim, Jason T Huse, Yujie Huang, et al.The Lancet. Oncology|January 2, 2013
Stereotactic body radiotherapy for oligometastasesAlison C Tree, Vincent S Khoo, Rosalind A Eeles, et al.The Lancet. Oncology|February 21, 2012
Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trialLuis Paz-Ares, Filippo de Marinis, Mircea Dediu, et al.Pageof 336